- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6277
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers ; volume:17 ; number:3 ; day:4 ; month:3 ; year:2016 ; pages:1-14 ; date:3.2016
Current treatment options in oncology ; 17, Heft 3 (4.3.2016), 1-14, 3.2016
- Creator
-
El-Taji, Omar M. S.
- Contributor
-
Alam, Sameer
Hussain, Syed A.
SpringerLink (Online service)
- DOI
-
10.1007/s11864-016-0390-8
- URN
-
urn:nbn:de:1111-201603075222
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- El-Taji, Omar M. S.
- Alam, Sameer
- Hussain, Syed A.
- SpringerLink (Online service)
Other Objects (12)
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors